Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,957 | -1,590 | -521 | -2,297 | -1,605 |
| Depreciation Amortization | 137 | 124 | 51 | 186 | 305 |
| Accounts receivable | 191 | 196 | 230 | -263 | -55 |
| Other Working Capital | 531 | 432 | 314 | 579 | 401 |
| Other Operating Activity | 621 | 528 | -60 | 1,115 | 551 |
| Operating Cash Flow | $-477 | $-311 | $14 | $-680 | $-402 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -6 | N/A | -5 | -5 |
| Purchase Sale Intangibles | -13 | -9 | -8 | -41 | -28 |
| Other Investing Activity | -13 | -9 | -8 | -41 | -28 |
| Investing Cash Flow | $-21 | $-15 | $-8 | $-46 | $-33 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 50 | 50 | 50 | 607 | 518 |
| Common Stock Issued | 560 | 520 | 85 | 225 | N/A |
| Other Financing Activity | -170 | -162 | -62 | -43 | -34 |
| Financing Cash Flow | $440 | $408 | $74 | $788 | $484 |
| Beginning Cash Position | 100 | 100 | 100 | 37 | 37 |
| End Cash Position | 41 | 182 | 179 | 100 | 86 |
| Net Cash Flow | $-58 | $83 | $80 | $63 | $49 |
| Free Cash Flow | |||||
| Operating Cash Flow | -477 | -311 | 14 | -680 | -402 |
| Capital Expenditure | -8 | -6 | N/A | -5 | -5 |
| Free Cash Flow | -485 | -317 | 14 | -685 | -407 |